Condition

Secondary Hyperparathyroidism clinical trials and research

• 6Clinical trials
• 23Countries

Newest Secondary Hyperparathyroidism clinical trials

All recruiting trials (6)

• CTAP101 extended-release capsules in kids with CKD and vitamin D insufficiency

  A daily bedtime dose of CTAP101 is being tested in children with CKD stages 3–4 and secondary hyperparathyroidism to see how the drug moves in the body, how it affects the body, and whether it is safe and tolerable.

  Recruiting Phase 2 OPKO Health, Inc. · Kansas City, Missouri and 4 other locations · NCT07494045

• Evaluating the effects of Pacitol Inj. on patients with chronic kidney disease and secondary hyperparathyroidism

  This study is testing if a new injection called Pacitol can help people with severe kidney disease and high parathyroid hormone levels feel better while they are on dialysis.

  Recruiting Boryung Pharmaceutical Co., Ltd · Goyang-si, Gyeonggi-do · NCT06126016

• Using microRNA to improve treatment for renal osteodystrophy

  This study is testing if a new method using microRNA can help doctors better understand bone health in people with chronic kidney disease and improve their treatment for renal osteodystrophy.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT05880914

• Comparing two surgical methods for treating secondary hyperparathyroidism

  This study is testing whether a surgery that includes transplanting parathyroid tissue works better than just removing the parathyroid glands alone for people with secondary hyperparathyroidism who are on long-term dialysis.

  Recruiting The Second Hospital of Nanjing Medical University · Nanjing · NCT04922892

• Treatment of secondary hyperparathyroidism in children on hemodialysis

  This study tests if a new medication called etelcalcetide can help children on hemodialysis lower their parathyroid hormone levels safely.

  Recruiting at 10 sites Phase 3 Amgen · Ghent and 22 other locations · NCT03969329

• Etelcalcetide treatment for children with kidney disease and high parathyroid hormone levels

  This study is testing if a new treatment called Etelcalcetide can help children with kidney disease and high parathyroid hormone levels feel better and avoid serious health problems.

  Recruiting at 19 sites Phase 3 Amgen · Los Angeles, California and 42 other locations · NCT03633708

Related topics

Quick answers

How many Secondary Hyperparathyroidism clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 23 countries. The most sites are in United States (3 trials), South Korea (2 trials), Belgium (1 trial), Czechia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →